News
-
-
-
COMMUNIQUÉ DE PRESSE
Linedata Services: Linedata confirme son éligibilité au PEA-PME
Linedata Services confirme son \xe9ligibilité au PEA-PME. Les actions restent \xe9ligibles au dispositif PEA-PME aprčs avoir respecté les critčres. Prochaine communication: chiffre d'affaires du 1er semestre 2024 le 23 juillet 2024 -
COMMUNIQUÉ DE PRESSE
Grupo EULEN Y Anew Climate Ampliarán en España Las Oportunidades De Mitigación Del Cambio Climático Basadas en La Naturaleza
Grupo EULEN and Anew Climate LLC partner to develop nature-based climate mitigation projects in Spain, aiming to create new carbon financing opportunities for forest landowners -
COMMUNIQUÉ DE PRESSE
Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional Diarrhea
Napo Pharmaceuticals announces positive results from a study on crofelemer, a plant-based prescription drug, for functional diarrhea patients, showing reduced abdominal pain and improved stool consistency -
-
-
COMMUNIQUÉ DE PRESSE
HBM portfolio company Yellow Jersey Therapeutics to be acquired for USD 1.25 billion
HBM Healthcare Investments announces Yellow Jersey Therapeutics acquisition by Johnson & Johnson for USD 1.25 billion. Transaction increases NAV per HBM share by CHF 8.70 (+3.5%) with expected cash inflow of USD 78 million -
COMMUNIQUÉ DE PRESSE
Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting
Mainz Biomed to present new pooled colorectal cancer screening data at ASCO 2024 Annual Meeting, showcasing significant advancements in early detection and diagnostic performance -
